541
Views
62
CrossRef citations to date
0
Altmetric
Research Article

Suitability of various excipients as carrier and coating materials for liquisolid compacts

, &
Pages 1200-1207 | Received 02 Nov 2010, Accepted 15 Feb 2011, Published online: 31 Mar 2011

References

  • Löbenberg R, Amidon GL. (2000). Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm, 50:3–12.
  • Kubo H, Osawa T, Takashima K, Mizobe M. (1996). Enhancement of oral bioavailability and pharmacological effect of 1-(3,4-dimethoxyphenyl)-2,3-bis(methoxycarbonyl)-4-hydroxy-6,7,8- trimethoxynaphthalene (TA-7552), a new hypocholesterolemic agent, by micronization in co-ground mixture with d-mannitol. Biol Pharm Bull, 19:741–747.
  • Smirnova I, Suttiruengwong S, Arlt W. (2004). Feasibility study of hydrophilic and hydrophobic silica aerogels as drug delivery systems. J Non-Cryst Solids, 350:54–60.
  • Smirnova I, Tuerk M, Wischumerski R, Wahl MA. (2005). Comparison of different methods for enhancing the dissolution rate of poorly soluble drugs: case of griseofulvin. Eng Life Sci, 5:277–280.
  • Barzegar-Jalali M, Valizadeh H, Shadbad MRS, Adibkia K, Mohammadi G, Farahani A et al. (2010). Cogrinding as an approach to enhance dissolution rate of a poorly water-soluble drug (gliclazide). Powder Technol, 197:150–158.
  • Ruan LP, Yu BY, Fu GM, Zhu DN. (2005). Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J Pharm Biomed Anal, 38:457–464.
  • Al-Hamidi H, Edwards AA, Mohammad MA, Nokhodchi A. (2010). To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations. Colloids Surf B Biointerfaces, 76:170–178.
  • Barzegar-Jalali M, Dastmalchi S. (2007). Kinetic analysis of chlorpropamide dissolution from solid dispersions. Drug Dev Ind Pharm, 33:63–70.
  • Corrigan OI. (1985). Mechanisms of dissolution of fast release solid dispersions. Drug Dev Ind Pharm, 11:697–724.
  • Pan RN, Chen JH, Chen RR. (2000). Enhancement of dissolution and bioavailability of piroxicam in solid dispersion systems. Drug Dev Ind Pharm, 26:989–994.
  • Valizadeh H, Zakeri-Milani P, Barzegar-Jalali M, Mohammadi G, Danesh-Bahreini MA, Adibkia K et al. (2007). Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers. Drug Dev Ind Pharm, 33:45–56.
  • Pouton CW. (2000). Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci, 11 (Suppl 2):S93–S98.
  • Javadzadeh Y, Shariati H, Movahhed-Danesh E, Nokhodchi A. (2009). Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts. Drug Dev Ind Pharm, 35:243–251.
  • Nokhodchi A, Hentzschel CM, Leopold CS. (2011). Drug release from liquisolid systems: speed it up, slow it down. Expert Opin Drug Deliv, 8:191–205.
  • Spireas S, Sadu S. (1998). Enhancement of prednisolone dissolution properties using liquisolid compacts. Int J Pharm, 166:177–188.
  • Spireas S, Sadu S, Grover R. (1998). In vitro release evaluation of hydrocortisone liquisolid tablets. J Pharm Sci, 87:867–872.
  • Spireas S, Wang T, Grover R. (1999). Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts. Drug Dev Ind Pharm, 25:163–168.
  • Spireas S. (2002). Liquisolid systems and methods of preparing same. US Patent 6423339B1.
  • Spireas SS, Jarowski CI, Rohera BD. (1992). Powdered solution technology: principles and mechanism. Pharm Res, 9:1351–1358.
  • Javadzadeh Y, Siahi-Shadbad MR, Barzegar-Jalali M, Nokhodchi A. (2005). Enhancement of dissolution rate of piroxicam using liquisolid compacts. Farmaco, 60:361–365.
  • Javadzadeh Y, Siahi MR, Asnaashari S, Nokhodchi A. (2007). An investigation of physicochemical properties of piroxicam liquisolid compacts. Pharm Dev Technol, 12:337–343.
  • Nokhodchi A, Javadzadeh Y, Siahi-Shadbad MR, Barzegar-Jalali M. (2005). The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J Pharm Pharm Sci, 8:18–25.
  • Yadav VB, Yadav AV. (2009). Improvement of solubility and dissolution of indomethacin by liquisolid and compaction granulation technique. J Pharm Sci Res, 1:44–51.
  • El-Houssieny BM, Wahman LF, Arafa NM. (2010). Bioavailability and biological activity of liquisolid compact formula of repaglinide and its effect on glucose tolerance in rabbits. Biosci Trends, 4:17–24.
  • Khaled KA, Asiri YA, El-Sayed YM. (2001). In vivo evaluation of hydrochlorothiazide liquisolid tablets in beagle dogs. Int J Pharm, 222:1–6.
  • Gonjari ID, Karmarkar AB, Hosmani AH. (2009). Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets. Dig J Nanomater Biostruct 4:651–661.
  • Javadzadeh Y, Musaalrezaei L, Nokhodchi A. (2008). Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices. Int J Pharm, 362:102–108.
  • Nokhodchi A, Aliakbar R, Desai S, Javadzadeh Y. (2010). Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release. Colloids Surf B Biointerfaces, 79:262–269.
  • Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A. (2007). Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int J Pharm, 341:26–34.
  • Schlack H, Bauer-Brandl A, Schubert R, Becker D. (2001). Properties of fujicalin, a new modified anhydrous dibasic calcium phosphate for direct compression: comparison with dicalcium phosphate dihydrate. Drug Dev Ind Pharm, 27:789–801.
  • Takami K, Machimura H, Takado K, Inagaki M, Kawashima Y. (1996). Novel preparation of free flowing spherically granulated dibasic calcium phosphate anhydrous for direct tabletting. Chem Pharm Bull, 44:868–870.
  • Sander C, Holm P. (2009). Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation. AAPS Pharmscitech, 10:1388–1395.
  • Yuasa H, Asahi D, Takashima Y, Kanaya Y, Shinozawa K. (1994). Application of calcium silicate for medicinal preparation. I. Solid preparation adsorbing an oily medicine to calcium silicate. Chem Pharm Bull, 42:2327–2331.
  • Brunauer S, Emmet PH, Teller E. (1938). Adsorption of gases in multimolecular layers. J Am Chem Soc, 60:309–319.
  • Fell JT, Newton JM. (1968). The tensile strength of lactose tablets. J Pharm Pharmacol, 20:657–659.
  • David ST, Augsburger LL. (1977). Plastic flow during compression of directly compressible fillers and its effect on tablet strength. J Pharm Sci, 66:155–159.
  • Lerk CF, Bolhuis GK, de Boer AH. (1979). Effect of microcrystalline cellulose on liquid penetration in and disintegration of directly compressed tablets. J Pharm Sci, 68:205–211.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.